FR2340935B1 - - Google Patents

Info

Publication number
FR2340935B1
FR2340935B1 FR7703913A FR7703913A FR2340935B1 FR 2340935 B1 FR2340935 B1 FR 2340935B1 FR 7703913 A FR7703913 A FR 7703913A FR 7703913 A FR7703913 A FR 7703913A FR 2340935 B1 FR2340935 B1 FR 2340935B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7703913A
Other languages
French (fr)
Other versions
FR2340935A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2340935A1 publication Critical patent/FR2340935A1/fr
Application granted granted Critical
Publication of FR2340935B1 publication Critical patent/FR2340935B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7703913A 1976-02-13 1977-02-11 Nouveaux derives d'alanine utiles comme agents anti-hypertensifs Granted FR2340935A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/657,829 US4073929A (en) 1976-02-13 1976-02-13 3-(2-Substitutedbenzimidazolyl) alanines

Publications (2)

Publication Number Publication Date
FR2340935A1 FR2340935A1 (fr) 1977-09-09
FR2340935B1 true FR2340935B1 (enExample) 1978-11-17

Family

ID=24638816

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703913A Granted FR2340935A1 (fr) 1976-02-13 1977-02-11 Nouveaux derives d'alanine utiles comme agents anti-hypertensifs

Country Status (9)

Country Link
US (1) US4073929A (enExample)
JP (1) JPS5297967A (enExample)
CH (1) CH625228A5 (enExample)
DE (1) DE2705892A1 (enExample)
DK (1) DK31277A (enExample)
FR (1) FR2340935A1 (enExample)
GB (1) GB1521025A (enExample)
NL (1) NL7700947A (enExample)
SE (1) SE7701506L (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070478A (en) * 1977-02-17 1978-01-24 Merck & Co., Inc. Benzimidazole substituted alanines
DE2801980A1 (de) * 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4537907A (en) * 1980-10-06 1985-08-27 University Of Illinois Foundation Hypnotic composition and method of inducing sleep
AU2001267465B2 (en) * 2000-05-30 2006-02-02 Boehringer Ingelheim Animal Health USA Inc. Methods for prevention of ulcers and improving physiological performance

Also Published As

Publication number Publication date
JPS5297967A (en) 1977-08-17
DK31277A (da) 1977-08-14
CH625228A5 (enExample) 1981-09-15
SE7701506L (sv) 1977-08-14
FR2340935A1 (fr) 1977-09-09
DE2705892A1 (de) 1977-08-18
NL7700947A (nl) 1977-08-16
GB1521025A (en) 1978-08-09
US4073929A (en) 1978-02-14

Similar Documents

Publication Publication Date Title
CS190860B1 (enExample)
JPS5336360U (enExample)
CS192684B1 (enExample)
CS190853B1 (enExample)
CS190780B1 (enExample)
CS175117B1 (enExample)
JPS5333892U (enExample)
CH600316A5 (enExample)
CH611656A5 (enExample)
CH598482A5 (enExample)
CH597020A5 (enExample)
CH600259A5 (enExample)
CH596798A5 (enExample)
CH600358A5 (enExample)
CH601585A5 (enExample)
CH602291A5 (enExample)
CH606491A5 (enExample)
CH606624A5 (enExample)
CH608345A5 (enExample)
CH609213A5 (enExample)
CH609391A5 (enExample)
CH609805A5 (enExample)
CH610132A5 (enExample)
CH610196A5 (enExample)
CH610840A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse